Press Releases from DelveInsight (693 total)
Chronic Hepatitis B Virus Pipeline: 50+ Companies Driving Next-Generation Therap …
The therapeutic landscape for Chronic Hepatitis B Virus (HBV) infection, a globally prevalent and potentially life-threatening liver disease, is rapidly evolving with innovative treatment candidates…
Laband Syndrome Market Outlook Poised for Scientific Attention by 2034 | DelveIn …
Laband Syndrome, also known as Zimmermann-Laband Syndrome, is an ultra-rare genetic disorder marked by gingival fibromatosis, distinctive facial features, joint hypermobility, and nail and bone…
Palmar Hyperhidrosis Market Set for Strong Growth by 2034 - DelveInsight | Key P …
Palmar Hyperhidrosis, a chronic dermatological condition characterized by excessive sweating of the palms, continues to impact quality of life and psychological well-being for millions of…
Vaso-Occlusive Crisis Market Set for Significant Growth by 2034 - DelveInsight | …
Vaso-Occlusive Crisis (VOC), a severe and painful complication of sickle cell disease, poses a substantial burden on patients and healthcare systems globally. The VOC market…
Leigh Syndrome Market Poised for Robust Growth by 2034: Unlocking New Therapies …
Leigh Syndrome, a rare and severe mitochondrial disorder predominantly affecting infants and young children, presents significant clinical challenges due to its complex neurological manifestations and…
Thymidine Kinase 2 Deficiency Market Set to Witness Significant Growth by 2034 | …
Thymidine Kinase 2 (TK2) Deficiency, a rare and progressive mitochondrial DNA depletion syndrome, presents considerable challenges in diagnosis, clinical management, and long-term outcomes due to…
BRAF-mutant Non-Small Cell Lung Cancer Pipeline: 10+ Companies Advancing Targete …
The treatment landscape for BRAF-mutant Non-Small Cell Lung Cancer (BRAF+ NSCLC), a molecular subtype of NSCLC driven by mutations in the BRAF gene, most commonly…
ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing…
Bruton's Tyrosine Kinase (BTK) Inhibitors Pipeline Set to Transform Oncology and …
The therapeutic landscape for Bruton's Tyrosine Kinase (BTK) inhibitors is undergoing a significant transformation, driven by the urgent need for targeted therapies in oncology and…
Fabry Disease Pipeline Overview: Over 18 Companies Driving Innovation in Targete …
The therapeutic landscape for Fabry disease, a rare genetic lysosomal storage disorder caused by deficient alpha-galactosidase A enzyme activity, is undergoing significant transformation. Biopharmaceutical developers…
Diabetes Pipeline: 200+ Companies Driving Innovation in Glucose Control, Disease …
The treatment landscape for diabetes is undergoing a significant transformation as the global burden of the disease continues to rise. With over 200 companies advancing…
Neisseria Meningitidis Meningitis Pipeline: Advancing Preventive and Therapeutic …
The therapeutic and preventive landscape for Neisseria Meningitidis Meningitis, a rapidly progressing and life-threatening bacterial infection of the membranes surrounding the brain and spinal cord,…
Neurofibromatosis Type 1 Pipeline: Emerging Targeted Therapies and Gene-Based Ap …
The treatment landscape for Neurofibromatosis Type 1 (NF1), a rare genetic disorder characterized by nerve sheath tumors, skin changes, and other systemic complications, is undergoing…
Lung Adenocarcinoma Pipeline: 25+ Companies Advancing Targeted Therapies and Imm …
The treatment landscape for lung adenocarcinoma, a leading form of non-small cell lung cancer (NSCLC), is undergoing a significant transformation. Once limited to traditional chemotherapy…
Liver Fibrosis Pipeline: 50+ Companies Advancing Antifibrotic Therapies and Dise …
The therapeutic landscape for liver fibrosis, a pathological scarring process resulting from chronic liver injury, is rapidly evolving, as biopharmaceutical innovators shift their focus from…
Essential Tremor Pipeline: Advancing Neuromodulation and Targeted Therapies to T …
The treatment landscape for Essential Tremor (ET), a prevalent neurological movement disorder characterized by involuntary rhythmic shaking, is undergoing a significant evolution. Historically managed with…
Diabetic Gastroparesis Pipeline: Emerging Therapies and Innovations in Gastroint …
The treatment landscape for Diabetic Gastroparesis (DG), a debilitating condition characterized by delayed gastric emptying in diabetic patients, is witnessing significant advancements as current therapeutic…
Cirrhosis Pipeline: Novel Antifibrotic Therapies and Regenerative Approaches Red …
The treatment landscape for cirrhosis, a progressive liver condition marked by fibrosis and compromised liver function, is witnessing a transformative shift as biopharmaceutical companies advance…
Cluster Headache Syndrome Pipeline: Advancing Targeted Therapies and Breakthroug …
The treatment landscape for Cluster Headache Syndrome (CHS), a debilitating and highly painful neurological condition, is evolving as new therapies are being developed to address…
Constipation Pipeline Insight, 2025: Key Players Shaping the Future, including A …
The treatment landscape for constipation, a prevalent gastrointestinal disorder, is undergoing significant advancements as new therapies aim to address the limitations of traditional treatments. As…
Critical Limb Ischemia Pipeline: Advancing Regenerative Therapies and Novel Inte …
The treatment landscape for Critical Limb Ischemia (CLI), the most severe form of peripheral arterial disease, is evolving rapidly as the limitations of conventional revascularization…
Chemotherapy-Induced Nausea and Vomiting Pipeline: Emerging Therapies and Key Co …
The therapeutic landscape for Chemotherapy-Induced Nausea and Vomiting (CINV), one of the most distressing side effects of cancer treatment, is evolving rapidly with a growing…
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements…
Chemotherapy-Induced Anemia Pipeline: Pioneering Treatments and Leading Companie …
The landscape for treating chemotherapy-induced anemia is evolving rapidly, driven by the development of novel therapies aimed at addressing the unmet needs of patients suffering…
Chondrosarcoma Pipeline: Advancing Therapeutics and 15+ Leading Companies Shapin …
The therapeutic landscape for Chondrosarcoma, a rare and aggressive bone cancer, is rapidly evolving, driven by advances in molecular biology, targeted therapies, and a deeper…
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying…
Inter Alpha Inhibitor Treatment Market Size in 7MM is expected to grow at a dece …
DelveInsight's "Inter Alpha Inhibitor Proteins Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Inter Alpha Inhibitor Proteins, historical and…
Cancer Cachexia Pipeline: Emerging Therapies Set to Transform the Cancer Cachexi …
The treatment landscape for Cancer Cachexia, a multifactorial syndrome characterized by progressive weight loss, muscle wasting, and fatigue in cancer patients, is undergoing significant evolution,…
Biliary Tumor Pipeline Insight 2025: 50+ Companies Advancing Groundbreaking Ther …
The treatment landscape for biliary tumors, including cholangiocarcinoma and gallbladder cancer, is witnessing significant innovation, propelled by an expanding pipeline of targeted therapies and immuno-oncology…
Bacteremia Pipeline: Emerging Therapies Set to Transform Bacteremia Treatment La …
The bacteremia treatment landscape is rapidly evolving, driven by innovative therapies from leading pharma and biotech companies targeting the complex pathogenesis of bacterial infections. Companies…
Ataxia Pipeline: Advancing Therapeutics and 32+ Leading Companies Shaping the At …
The therapeutic landscape for Ataxia, a group of rare neurological disorders characterized by impaired coordination and balance, is witnessing significant momentum, driven by advances in…
Aspergillosis Pipeline: 20+ Promising Therapies Poised to Redefine the Aspergill …
The treatment paradigm for Aspergillosis, a serious fungal infection primarily affecting immunocompromised individuals, is rapidly evolving with a robust pipeline of antifungal agents under clinical…
Primary Myelofibrosis Pipeline: 55+ Companies Driving Innovations in Treatment a …
The treatment landscape for Primary Myelofibrosis (PMF), a rare and chronic bone marrow disorder, is advancing significantly, fueled by innovative therapies from leading pharmaceutical and…
Primary Open Angle Glaucoma Clinical Trial Pipeline: Emerging Therapies Shaping …
The treatment landscape for Primary Open Angle Glaucoma (POAG), a leading cause of blindness worldwide, is undergoing significant transformation, driven by cutting-edge therapies from top…
Progressive Familial Intrahepatic Cholestasis Pipeline: Promising Therapies Shap …
The treatment landscape for Progressive Familial Intrahepatic Cholestasis (PFIC), a rare and progressive liver disorder, is evolving rapidly, driven by innovative therapies from leading pharmaceutical…
Prurigo Nodularis Pipeline: Emerging Therapies Set to Reshape the Prurigo Nodula …
The treatment landscape of Prurigo Nodularis (PN), a chronic, intensely pruritic skin disorder, is undergoing a dynamic transformation, fueled by a growing pipeline of novel…
Psoriasis Vulgaris Pipeline: 45+ Therapies in Development by Pharma Leaders Set …
The psoriasis vulgaris treatment landscape is witnessing robust advancement, spearheaded by biopharmaceutical innovators such as Xencor, Ono Pharmaceutical Co. Ltd, Boehringer Ingelheim, GC Cell Corporation,…
Short Bowel Syndrome Pipeline: 18+ Companies Driving Innovation in Rare Gastroin …
The treatment landscape for Short Bowel Syndrome (SBS) is witnessing meaningful progress, led by innovators like VectivBio, Zealand Pharma, 9 Meters Biopharma, Hanmi Pharmaceutical, Adocia,…
LEQVIO Sales Surge Globally, Driven by Rising Cardiovascular Risk Awareness and …
DelveInsight's "LEQVIO Market Size, Forecast, and Market Insight Report" delivers a comprehensive analysis of LEQVIO's commercial performance, competitive positioning, and future outlook across key global…
Necrotizing Enterocolitis Pipeline: Breakthrough Therapeutics Advancing in Neona …
Necrotizing Enterocolitis (NEC), a devastating gastrointestinal disease affecting neonates, especially preterm infants, has long lacked effective treatment beyond supportive care. However, innovative biotech companies such…
Steroid-Refractory Acute Graft-Versus-Host Disease Pipeline: Innovation Surge as …
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) represents a severe and life-threatening complication of allogeneic stem cell transplantation, with limited treatment options and poor prognosis. Key companies,…
Polycythemia Vera Pipeline: 10+ Therapies in Development by Pharma Giants Poised …
The Polycythemia Vera (PV) treatment landscape is undergoing significant evolution, driven by leading biopharmaceutical companies such as Protagonist Therapeutics, Italfarmaco, Ionis Pharmaceuticals, and Perseus Proteomics.…
Cystitis Pipeline: 15+ Innovators Advancing Disease-Modifying and Symptomatic Th …
Cystitis, an inflammation of the bladder often caused by bacterial infection, has drawn significant attention from over 15 key companies, including Seikagaku Corporation, Lipella Pharmaceuticals,…
Chemotherapy-Induced Anemia Pipeline: 3+ Companies Advancing Novel Erythropoieti …
Chemotherapy-Induced Anemia (CIA) is a common and debilitating side effect of cancer treatment, significantly impacting patients' quality of life, fatigue levels, and treatment adherence. With…
Brain Hemorrhage Pipeline: 10+ Innovators Advancing Neuroprotective and Regenera …
Brain hemorrhage, a life-threatening condition characterized by bleeding within the brain tissue, has spurred the development of innovative treatments by more than 10 key pharmaceutical…
Candidiasis Pipeline: 15+ Key Innovators Advancing Therapeutic Solutions from Ci …
Candidiasis, a fungal infection caused by Candida species, is a growing concern in both immunocompromised and healthy populations. The candidiasis pipeline is being advanced by…
Cachexia Pipeline: 27+ Innovators Advancing Anti-Wasting and Metabolic Therapies …
Cachexia, a multifactorial syndrome marked by severe muscle wasting and weight loss, especially in cancer and chronic illnesses, has attracted growing R&D interest. Over 27…
Anthrax Pipeline: 10+ Companies Advancing Cutting-Edge Vaccines and Therapeutics …
The anthrax treatment market is evolving, with focused R&D efforts aimed at biodefense and preparedness for high-threat pathogens. Key players, including GC Pharma, Emergent BioSolutions,…
Angina (Angina Pectoris) Pipeline: 10+ Companies Transforming Chest Pain Managem …
The angina therapeutics pipeline is experiencing a renaissance, driven by pharmaceutical companies such as Abbott Laboratories, AstraZeneca, Bayer AG, and Bristol-Myers Squibb. With a focus…
Anaplastic Astrocytoma Pipeline: 15+ Biopharma Companies Advancing Targeted Ther …
The anaplastic astrocytoma treatment pipeline is gaining momentum with the introduction of precision therapies, immunotherapies, and novel alkylating agents. Companies like Orbus Therapeutics, Cothera Bioscience,…
